• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊立替康联合顺铂治疗胃混合性神经内分泌-非神经内分泌肿瘤异时性肝转移后长期生存并完全缓解:一例报告

Long-term survival with complete remission after irinotecan plus cisplatin therapy for metachronous liver metastasis from a gastric mixed neuroendocrine-non-neuroendocrine neoplasm: a case report.

作者信息

Yasuda Kazuhiro, Inokuchi Shoichi, Tsutsumi Satoshi, Takayama Hiroomi, Ikebe Masahiko, Bandou Toshio, Utsunomiya Tohru, Urabe Shogo

机构信息

Department of Surgery, Oita Prefectural Hospital, 8-1 Bunyo, Oita, 870-8511, Japan.

Department of Pathology, Oita Prefectural Hospital, Oita, Japan.

出版信息

Clin J Gastroenterol. 2025 May 1. doi: 10.1007/s12328-025-02139-6.

DOI:10.1007/s12328-025-02139-6
PMID:40310583
Abstract

Gastric mixed neuroendocrine-non-neuroendocrine neoplasm, which consists of both exocrine and endocrine components, is rare and exhibits aggressive biological behavior and poor prognosis. A 64-year-old man underwent investigation for abdominal pain. An endoscopic examination revealed a 30-mm protruded lesion in the gastric antrum for which distal gastrectomy with lymph node dissection was performed. Histopathological examination showed two distinct components, an adenocarcinoma component and neuroendocrine carcinoma component, with immunohistochemical staining positive for CD56, chromogranin A, and synaptophysin. The final diagnosis was mixed neuroendocrine-non-neuroendocrine neoplasm, pT2, pN3, M0, stage IIIA. Multiple liver metastases were detected 3 months after surgery. The patient received irinotecan plus cisplatin therapy, which was effective, and the liver metastases disappeared. The patient remains alive, without any recurrence, more than 10 years after surgery. We present a rare case of gastric mixed neuroendocrine-non-neuroendocrine neoplasm and review the literature to contribute to improving our understanding of this kind of tumor.

摘要

胃混合性神经内分泌-非神经内分泌肿瘤由外分泌和内分泌成分组成,较为罕见,具有侵袭性生物学行为且预后较差。一名64岁男性因腹痛接受检查。内镜检查发现胃窦有一个30毫米的突出病变,遂行远端胃切除术及淋巴结清扫术。组织病理学检查显示有两种不同成分,即腺癌成分和神经内分泌癌成分,免疫组化染色显示CD56、嗜铬粒蛋白A和突触素呈阳性。最终诊断为混合性神经内分泌-非神经内分泌肿瘤,pT2,pN3,M0,ⅢA期。术后3个月检测到多发肝转移。患者接受了伊立替康联合顺铂治疗,治疗有效,肝转移消失。患者术后存活超过10年,无任何复发。我们报告一例罕见的胃混合性神经内分泌-非神经内分泌肿瘤病例,并回顾文献以增进我们对这类肿瘤的认识。

相似文献

1
Long-term survival with complete remission after irinotecan plus cisplatin therapy for metachronous liver metastasis from a gastric mixed neuroendocrine-non-neuroendocrine neoplasm: a case report.伊立替康联合顺铂治疗胃混合性神经内分泌-非神经内分泌肿瘤异时性肝转移后长期生存并完全缓解:一例报告
Clin J Gastroenterol. 2025 May 1. doi: 10.1007/s12328-025-02139-6.
2
Chemotherapy for advanced gastric cancer.晚期胃癌的化疗
Cochrane Database Syst Rev. 2017 Aug 29;8(8):CD004064. doi: 10.1002/14651858.CD004064.pub4.
3
Chemotherapy for advanced gastric cancer.晚期胃癌的化疗
Cochrane Database Syst Rev. 2010 Mar 17(3):CD004064. doi: 10.1002/14651858.CD004064.pub3.
4
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.辅助纳武利尤单抗联合化疗对比安慰剂联合化疗用于 D2 或更广泛淋巴结清扫术后的 III 期胃癌或胃食管结合部癌(ATTRACTION-5):一项随机、多中心、双盲、安慰剂对照的 III 期临床试验。
Lancet Gastroenterol Hepatol. 2024 Aug;9(8):705-717. doi: 10.1016/S2468-1253(24)00156-0. Epub 2024 Jun 18.
5
Long-term survival after chemotherapy combined immunotherapy for recurrent mixed neuroendocrine-non-neuroendocrine neoplasms of the common bile duct.化疗联合免疫疗法治疗胆总管复发性混合性神经内分泌-非神经内分泌肿瘤后的长期生存情况。
Clin J Gastroenterol. 2025 Apr 17. doi: 10.1007/s12328-025-02128-9.
6
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.伊立替康、奥沙利铂和雷替曲塞用于治疗晚期结直肠癌:系统评价与经济学评估
Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. doi: 10.3310/hta12150.
7
Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases.经动脉(化疗)栓塞与全身化疗治疗结直肠癌肝转移。
Cochrane Database Syst Rev. 2024 Aug 9;8(8):CD012757. doi: 10.1002/14651858.CD012757.pub2.
8
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study.赞布替尼联合化疗作为HER2阳性晚期胃食管腺癌患者的一线治疗:一项多中心、单臂、2期研究的主要结果
Lancet Oncol. 2025 May 30. doi: 10.1016/S1470-2045(25)00287-6.
9
Postoperative adjuvant chemotherapy in rectal cancer operated for cure.针对接受根治性手术的直肠癌患者的术后辅助化疗。
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD004078. doi: 10.1002/14651858.CD004078.pub2.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
Advanced esophagogastric junction mixed neuroendocrine-non-neuroendocrine neoplasm with long-term recurrence-free survival.晚期食管胃交界部混合性神经内分泌-非神经内分泌肿瘤伴长期无复发生存
Surg Case Rep. 2024 Sep 11;10(1):217. doi: 10.1186/s40792-024-02011-8.
2
Long-term survival of gastric mixed neuroendocrine-non-neuroendocrine neoplasm: Two case reports.胃神经内分泌-非神经内分泌混合性肿瘤的长期生存:两例报告
World J Clin Cases. 2022 Aug 6;10(22):7936-7943. doi: 10.12998/wjcc.v10.i22.7936.
3
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial.
依托泊苷和顺铂与伊立替康和顺铂治疗消化系统晚期神经内分泌癌患者的疗效:TOPIC-NEC 阶段 3 随机临床试验。
JAMA Oncol. 2022 Oct 1;8(10):1447-1455. doi: 10.1001/jamaoncol.2022.3395.
4
Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms.胃神经内分泌癌和混合性神经内分泌-非神经内分泌肿瘤的长期手术结果。
World J Surg Oncol. 2022 May 24;20(1):165. doi: 10.1186/s12957-022-02625-y.
5
Clinicopathologic and Molecular Characteristics of Gastrointestinal MiNENs.胃肠道混合性神经内分泌-非神经内分泌肿瘤的临床病理及分子特征
Front Oncol. 2021 Aug 4;11:709097. doi: 10.3389/fonc.2021.709097. eCollection 2021.
6
Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma.胃神经内分泌癌、混合性腺神经内分泌癌和腺癌的生存和复发模式比较。
JAMA Netw Open. 2021 Jul 1;4(7):e2114180. doi: 10.1001/jamanetworkopen.2021.14180.
7
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis.混合性神经内分泌-非神经内分泌肿瘤:对一种有争议且被低估的诊断的系统评价
J Clin Med. 2020 Jan 19;9(1):273. doi: 10.3390/jcm9010273.
8
Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.胃肠道混合性腺神经内分泌癌 (MANEC):13 例微卫星稳定病例的免疫组织化学研究。
Pathol Res Pract. 2019 Dec;215(12):152697. doi: 10.1016/j.prp.2019.152697. Epub 2019 Oct 23.
9
Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: a case report and literature review.Vater壶腹混合性腺神经内分泌癌:一例报告及文献复习
Clin J Gastroenterol. 2020 Feb;13(1):37-45. doi: 10.1007/s12328-019-01009-2. Epub 2019 Jul 24.
10
Long-term disease free survival of gastric mixed adenoneuroendocrine carcinoma treated with multimodality therapy: A case report.多模式治疗胃混合性腺神经内分泌癌的长期无病生存:一例报告
Mol Clin Oncol. 2018 May;8(5):653-656. doi: 10.3892/mco.2018.1594. Epub 2018 Mar 26.